Cba Florida, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
March 25, 2020 at 08:33 pm
Share
CBA Florida, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced operating loss was USD 639,378 compared to USD 3.876 million a year ago. Net loss was USD 36,849 compared to net income of USD 13.173 million a year ago. Basic eps was USD 0 compared to USD 0.01 a year ago.
CBA Florida, Inc., formerly Cord Blood America, Inc., through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. The Company's subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. The Company and its subsidiaries provides private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord's operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.
CBA FLORIDA, INC. 